“Doc, I don’t trust the Covid-19 vaccine because it’s too rushed. Normally, vaccines take 7-10 years to research.” Dr Khor SK in his opinion piece reassures that the Covid-19 vaccine is as safe as possible, with only one year of effective and accelerated research.
Tag: COVID-19
[EXPERT REACTION] Britain’s new COVID-19 strain
Following reports of a new strain of the coronavirus that is more infectious circulating in parts of the UK, British Health Secretary Matt Hancock on Sunday (20 Dec) said that the government has imposed a strict Christmas lockdown in London and southeast England.
[FACT SHEET] What is the Pfizer-BioNTech COVID-19 Vaccine?
Malaysia is expected to receive the first batch of the COVID-19 vaccine jointly developed by Pfizer and BioNTech in February next year. This fact sheet contains information to help you understand the risks and benefits of the Pfizer-BioNTech COVID-19 Vaccine.
[FEATURE ARTICLE] In Conversation with the 2020 Mahathir Science Award Recipient
This year, the Mahathir Science Award – the most prestigious science award for tropical sciences was presented to Professor Sir Alimuddin Zumla of University College London, in recognition of his exceptional, globally acknowledged research in infectious diseases which is relevant to the development and enhancement of health policy.
[MEDIA RELEASE] All Levels of Society Must Comply with SOPs – AMM
The Academy of Medicine of Malaysia (AMM) urged the government to enforce mandatory quarantine in designated quarantine centres for Sabah returnees. It has been proven in other countries, such as China and Singapore where compliance rates are high, that home quarantines are not as effective in curbing spread.
[Q&A] COVID-19: What is a Super Spreader?
The latest Sivagangga cluster from Kedah was suspected of being caused by a super spreader strain of the COVID-19 virus that originated from Egypt and Pakistan. Health authorities believed there is a high probability that the cluster is a super spreader because of its higher transmission rate compared to previous COVID-19 clusters. We spoke to Associate Prof. Dr Chan Yoke Fun, Virologist & Senior Lecturer at the Department of Medical Microbiology, Faculty of Medicine, University of Malaya to learn more.
[MEDIA RELEASE] Impact of COVID-19 on Hepatitis Elimination
Viral hepatitis is a communicable disease that can cause serious liver damage and liver cancer. Deaths from viral hepatitis, the majority (96%) are due to hepatitis B and C, are rising worldwide compared to the downward trend for the other three most common causes of communicable diseases. However, hepatitis is preventable, treatable, and for Hepatitis C, curable with timely treatment.
[MEDIA RELEASE] WHO discontinues hydroxychloroquine and lopinavir/ritonavir treatment arms for COVID-19
These interim trial results show that hydroxychloroquine and lopinavir/ritonavir produce little or no reduction in the mortality of hospitalized COVID-19 patients when compared to standard of care. Solidarity trial investigators will interrupt the trials with immediate effect.
[OPINION] Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
As of 12 May 2020, 4,425,094 people have been infected with SARS-CoV-2 with deaths reaching 297,723.Doctors are desperately looking for an effective drug, and there have been a number of candidates on trial; one of them, remdesivir, is probably the most exciting of all. This is the drug developed for the Ebola epidemic in 2015, but it was found to be less effective in clinical trials than in in vitro studies. Is remdesivir the panacea for COVID-19?
[EXPERT REACTION] Dexamethasone: Effective Treatment for COVID-19?
A research team at Oxford University has recently found a cheap and widely available drug called dexamethasone that can be used to effectively treat severe forms of COVID-19. The 'breakthrough' drug has shown to significantly reduce the number of deaths among those seriously ill with the coronavirus. We asked experts to comment on the effectiveness of the drug in treating COVID-19.
You must be logged in to post a comment.